The Risk Factor and Outcome of Metachronous Periprosthetic Joint Infections: A Retrospective Analysis With a Minimum Ten-Year Follow-Up

J Arthroplasty. 2021 Nov;36(11):3734-3740. doi: 10.1016/j.arth.2021.07.019. Epub 2021 Aug 5.

Abstract

Background: Patients with multiple prosthetic joints are at risk of developing periprosthetic joint infections (PJIs). We aimed to determine whether PJI development at one site may lead to infection at another prosthetic joint site and assess the risk factors leading to this subsequent infection.

Methods: We reviewed all cases (294 patients with first-time PJI [159 hips, 135 knees]) with PJI treated at our institute between January 1994 and December 2020. The average follow-up period was 11.2 years (range 10.1-23.2). Patients were included if they had at least one other prosthetic joint at the time of developing a single PJI (96 patients). Patients with synchronous PJI were excluded from the study. The incidence of metachronous PJI was assessed, and the risk factors were determined by comparing different characteristics between patients without metachronous PJI.

Results: Of the 96 patients, 19.79% developed metachronous PJI. The identified causative pathogen was the same in 63.16% of the patients. The time to developing a second PJI was 789.84 days (range 10-3386). The identified risk factors were PJI with systemic inflammatory response syndrome, ≥3 stages of resection arthroplasty, and PJI caused by methicillin-resistant Staphylococcus aureus.

Conclusion: PJI may predispose patients to subsequent PJI in another prosthesis with identified risks. Most causative organisms of metachronous PJI were the same species as those of the first PJI. We believe that bacteremia may be involved in pathogenesis, but further research is required.

Keywords: metachronous periprosthetic joint infection; methicillin-resistant Staphylococcus aureus; multiple prosthetic joints; resection arthroplasty; systemic inflammatory response syndrome.

MeSH terms

  • Arthroplasty, Replacement, Hip* / adverse effects
  • Follow-Up Studies
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Prosthesis-Related Infections* / epidemiology
  • Prosthesis-Related Infections* / etiology
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections* / epidemiology